.
.
.
.
Coronavirus

Japan to extend COVID state of emergency in Tokyo area until last week of September

Published: Updated:

The Japanese government plans to extend a state of emergency in and around Tokyo until the last week of September in a further bid to contain the coronavirus epidemic, the Mainichi newspaper reported on Saturday.

Japan last month expanded emergency curbs to cover about 80 percent of its population until Sept. 12, but the number of severe cases and the strain on the medical system have not eased sufficiently in Tokyo and surrounding areas to allow the restrictions to be lifted.

For more coronavirus news, visit our dedicated page.

The government plans to extend them by about two weeks in Tokyo and neighboring Kanagawa, Saitama and Chiba prefectures, the Mainichi said, without citing sources.

Under the state of emergency, the government has sought to reduce foot traffic by asking restaurants to shorten their hours and refrain from serving alcohol, and companies to let staff work from home more frequently.

The extension would take the curbs through the fourth week of September, which has two public holidays and during which many people make travel plans.

The government will also consider an extension in hard-hit areas in central and western Japan, including Aichi - home of Toyota Motor - and Osaka, the paper said, adding a decision would likely be made in the middle of next week.

It will consider downgrading or lifting states of emergency in prefectures that have seen hospital beds free up to non-critical levels, the Mainichi said.

Japan is battling its fifth and biggest wave of COVID-19 cases, driven by the highly infectious Delta variant. On Friday, new daily nationwide cases hit 16,729, with 63 deaths.

Read more:

Saudi Arabia records 138 COVID-19 cases and seven deaths in 24 hours

New Zealand COVID outbreak claims first death in six months, toll at 27 so far

Over 80 pct of American adults now have COVID-19 antibodies: Blood donor study

Breast milk of vaccinated mothers contains COVID-fighting antibodies, study finds